Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond)

Project Information

HIT-CF

Grant agreement ID: 755021

DOI

10.3030/755021

Project closed

EC signature date 28 November 2017

Start date 1 January 2018

End date 30 June 2025

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 6 701 365,00

EU contribution

€ 6 701 365,00

Coordinated by

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Netherlands

• New approach to advance drug pipeline for cystic fibrosis
  EN